Leavell Investment Management, Inc. Amgen Inc Transaction History

Leavell Investment Management, Inc.

$1.79 Billion
Q2 2024

A detailed history of Leavell Investment Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 12,431 shares of AMGN stock, worth $4.01 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

12,431

Previous 12,583 1.21%

Holding current value

$4.01 Million

Previous $3.58 Million 8.58%

% of portfolio

0.22%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $39,938 - $48,535	-152 Reduced 1.21%	12,431 $3.88 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $34,684 - $41,868	-129 Reduced 1.01%	12,583 $3.58 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $338,546 - $381,921	1,324 Added 11.63%	12,712 $3.66 Million
Q3 2023 Oct 16, 2023	SELL	$218.65 - $271.46 $79,151 - $98,268	-362 Reduced 3.08%	11,388 $3.06 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $21,855 - $25,843	102 Added 0.88%	11,750 $2.61 Million
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $59,834 - $72,928	-265 Reduced 2.22%	11,648 $2.82 Million
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $57,257 - $72,752	-250 Reduced 2.06%	11,913 $3.13 Million
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 0.41%	12,163 $2.74 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $6,690 - $7,445	29 Added 0.24%	12,213 $2.97 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $44,073 - $48,756	201 Added 1.68%	12,184 $2.95 Million
Q4 2021 Jan 20, 2022	SELL	$198.88 - $227.6 $4,773 - $5,462	-24 Reduced 0.2%	11,983 $2.7 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $32,265 - $37,802	152 Added 1.28%	12,007 $2.55 Million
Q1 2021 Apr 15, 2021	BUY	$221.91 - $258.6 $49,485 - $57,667	223 Added 1.92%	11,855 $2.95 Million
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $37,866 - $45,092	-175 Reduced 1.48%	11,632 $2.67 Million
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $94,605 - $121,600	500 Added 4.42%	11,807 $2.85 Million
Q3 2019 Oct 28, 2019	BUY	$174.11 - $208.62 $112,649 - $134,977	647 Added 6.07%	11,307 $2.19 Million
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $10,002 - $11,724	-60 Reduced 0.56%	10,660 $1.96 Million
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $14,469 - $16,310	80 Added 0.75%	10,720 $2.04 Million
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $30,149 - $35,194	169 Added 1.61%	10,640 $2.07 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $2,779 - $3,133	-15 Reduced 0.14%	10,471 $2.17 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $10,793 - $12,123	65 Added 0.62%	10,486 $1.94 Million
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $25,414 - $29,700	-150 Reduced 1.42%	10,421 $1.78 Million
Q4 2017 Jan 11, 2018	SELL	$168.79 - $188.59 $350,239 - $391,324	-2,075 Reduced 16.41%	10,571 $1.84 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $2.12 Million - $2.42 Million	12,646	12,646 $2.36 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leavell Investment Management, Inc. with notifications on news.

Account

Leavell Investment Management, Inc. Amgen Inc Transaction History